RANDOMIZED PHASE II STUDY OF NIVOLUMAB WITH OR WITHOUT IPILIMUMAB IN PATIENTS WITH METASTATIC OR UNRESECTABLE SARCOMA - Regional Cancer Care Associates LLC

Clinical Trials

RANDOMIZED PHASE II STUDY OF NIVOLUMAB WITH OR WITHOUT IPILIMUMAB IN PATIENTS WITH METASTATIC OR UNRESECTABLE SARCOMA

Type of Cancer
Skin and Soft Tissue
Locations
Hackensack
Sponsor
Alliance
Protocol Number
A091401
Cancer Diagnosis
To Learn More Call
201-510-0910